Failure of inosine to prevent ischemic damage in the canine and rat kidney models

S. E. Okiye, H. Zincke, G. Aydin, A. R. Zinsmeister

Research output: Contribution to journalArticle

Abstract

Intravenous, renal arterial, and intraperitoneal administration of inosine at dosages of 100 to 200 mg/kg, 160 mg/kg, and 200 mg/kg, respectively, in the dog and rat was used to test its efficacy in preventing ischemic damage after 60 min of warm ischemia in an in situ solitary renal model. No improvement of renal function as compared with a control and a conventional mannitol/furosemide treatment group was detected. Rather, inosine at dosages of{succeeds or equal to}160 mg/kg resulted in significantly impaired renal function in the experimental groups of the dog model; no improvement was observed in the rat model. These results suggest that the use of inosine in human renal surgery and preservation should be approached cautiously.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalUrological Research
Volume12
Issue number2
DOIs
StatePublished - Apr 1984

Fingerprint

Inosine
Canidae
Kidney
Dogs
Warm Ischemia
Furosemide
Mannitol

Keywords

  • Inosine
  • Renal ischemia
  • Renal ischemic damage
  • Renal transplantation

ASJC Scopus subject areas

  • Urology

Cite this

Failure of inosine to prevent ischemic damage in the canine and rat kidney models. / Okiye, S. E.; Zincke, H.; Aydin, G.; Zinsmeister, A. R.

In: Urological Research, Vol. 12, No. 2, 04.1984, p. 121-124.

Research output: Contribution to journalArticle

Okiye, SE, Zincke, H, Aydin, G & Zinsmeister, AR 1984, 'Failure of inosine to prevent ischemic damage in the canine and rat kidney models', Urological Research, vol. 12, no. 2, pp. 121-124. https://doi.org/10.1007/BF00257177
Okiye, S. E. ; Zincke, H. ; Aydin, G. ; Zinsmeister, A. R. / Failure of inosine to prevent ischemic damage in the canine and rat kidney models. In: Urological Research. 1984 ; Vol. 12, No. 2. pp. 121-124.
@article{3accd32dd7db4a819f2725fc8f3e1624,
title = "Failure of inosine to prevent ischemic damage in the canine and rat kidney models",
abstract = "Intravenous, renal arterial, and intraperitoneal administration of inosine at dosages of 100 to 200 mg/kg, 160 mg/kg, and 200 mg/kg, respectively, in the dog and rat was used to test its efficacy in preventing ischemic damage after 60 min of warm ischemia in an in situ solitary renal model. No improvement of renal function as compared with a control and a conventional mannitol/furosemide treatment group was detected. Rather, inosine at dosages of{succeeds or equal to}160 mg/kg resulted in significantly impaired renal function in the experimental groups of the dog model; no improvement was observed in the rat model. These results suggest that the use of inosine in human renal surgery and preservation should be approached cautiously.",
keywords = "Inosine, Renal ischemia, Renal ischemic damage, Renal transplantation",
author = "Okiye, {S. E.} and H. Zincke and G. Aydin and Zinsmeister, {A. R.}",
year = "1984",
month = "4",
doi = "10.1007/BF00257177",
language = "English (US)",
volume = "12",
pages = "121--124",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Failure of inosine to prevent ischemic damage in the canine and rat kidney models

AU - Okiye, S. E.

AU - Zincke, H.

AU - Aydin, G.

AU - Zinsmeister, A. R.

PY - 1984/4

Y1 - 1984/4

N2 - Intravenous, renal arterial, and intraperitoneal administration of inosine at dosages of 100 to 200 mg/kg, 160 mg/kg, and 200 mg/kg, respectively, in the dog and rat was used to test its efficacy in preventing ischemic damage after 60 min of warm ischemia in an in situ solitary renal model. No improvement of renal function as compared with a control and a conventional mannitol/furosemide treatment group was detected. Rather, inosine at dosages of{succeeds or equal to}160 mg/kg resulted in significantly impaired renal function in the experimental groups of the dog model; no improvement was observed in the rat model. These results suggest that the use of inosine in human renal surgery and preservation should be approached cautiously.

AB - Intravenous, renal arterial, and intraperitoneal administration of inosine at dosages of 100 to 200 mg/kg, 160 mg/kg, and 200 mg/kg, respectively, in the dog and rat was used to test its efficacy in preventing ischemic damage after 60 min of warm ischemia in an in situ solitary renal model. No improvement of renal function as compared with a control and a conventional mannitol/furosemide treatment group was detected. Rather, inosine at dosages of{succeeds or equal to}160 mg/kg resulted in significantly impaired renal function in the experimental groups of the dog model; no improvement was observed in the rat model. These results suggest that the use of inosine in human renal surgery and preservation should be approached cautiously.

KW - Inosine

KW - Renal ischemia

KW - Renal ischemic damage

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=0021344562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021344562&partnerID=8YFLogxK

U2 - 10.1007/BF00257177

DO - 10.1007/BF00257177

M3 - Article

C2 - 6429919

AN - SCOPUS:0021344562

VL - 12

SP - 121

EP - 124

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

IS - 2

ER -